Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
Oct 11, 2023
46:28
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
Oncology Today with Dr Neil Love